Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis

Journal of the American Geriatrics Society

Volumn 61, Issue 6, 2013, Pages 896-901

  McAdams Demarco, Mara A ^a,b   Law, Andrew ^a,b   Salter, Megan L ^a,b   Boyarsky, Brian ^a   Gimenez, Luis ^a,c,d   Jaar, Bernard G ^a,b,c,d   Walston, Jeremy D ^a   Segev, Dorry L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c NEPHROLOGY CENTER OF MARYLAND   (United States)

^d GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

frailty; hemodialysis; hospitalization; mortality

Indexed keywords

ADULT; AGED; ARTICLE; COMMUNITY; COMORBIDITY; DEATH; DISABILITY; FEMALE; FRAIL ELDERLY; HEMODIALYSIS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE;

AGED; AGED, 80 AND OVER; DISABILITY EVALUATION; DISABLED PERSONS; FEMALE; FOLLOW-UP STUDIES; FRAIL ELDERLY; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MARYLAND; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SURVIVAL RATE;

EID: 84879128554     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12266     Document Type: Article

References (44)

1. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56A: M146-M156.
2. Diaz de Leon Gonzalez E, Tamez Perez HE, Gutierrez Hermosillo H, et al. Frailty and its association with mortality, hospitalization and functional dependence in Mexicans aged 60-years or older. Med Clin 2012; 138: 468-474.
3. Puts MT, Monette J, Girre V, et al. Does frailty predict hospitalization, emergency department visits, and visits to the general practitioner in older newly-diagnosed cancer patients? Results of a prospective pilot study. Crit Rev Oncol Hematol 2010; 76: 142-151.
4. Bouillon K, Sabia S, Jokela M, et al. Validating a widely used measure of frailty: Are all sub-components necessary? Evidence from the Whitehall II cohort study. Age (Dordr) 2012; [Epub ahead of print].
5. Avila-Funes JA, Helmer C, Amieva H, et al. Frailty among community-dwelling elderly people in France: The Three-City Study. J Gerontol A Biol Sci Med Sci 2008; 63A: 1089-1096.
6. Boyd CM, Xue QL, Simpson CF, et al. Frailty, hospitalization, and progression of disability in a cohort of disabled older women. Am J Med 2005; 118: 1225-1231.
7. Mitnitski A, Fallah N, Rockwood MR, et al. Transitions in cognitive status in relation to frailty in older adults: A comparison of three frailty measures. J Nutr Health Aging 2011; 15: 863-867.
8. Vaz Fragoso CA, Enright PL, McAvay G, et al. Frailty and respiratory impairment in older persons. Am J Med 2012; 125: 79-86.
9. Woo J, Leung J, Morley JE,. Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation. J Am Geriatr Soc 2012; 60: 1478-1486.
10. U.S. Renal Data System. Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, 2011.
11. Bazeley J, Bieber B, Li Y, et al. C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol 2011; 6: 2452-2461.
12. Quinn RR, Laupacis A, Hux JE, et al. Predicting the risk of 1-year mortality in incident dialysis patients: Accounting for case-mix severity in studies using administrative data. Med Care 2011; 49: 257-266.
13. Wagner M, Ansell D, Kent DM, et al. Predicting mortality in incident dialysis patients: An analysis of the United Kingdom Renal Registry. Am J Kidney Dis 2011; 57: 894-902.
14. Miskulin D, Bragg-Gresham J, Gillespie BW, et al. Key comorbid conditions that are predictive of survival among hemodialysis patients. Clin J Am Soc Nephrol 2009; 4: 1818-1826.
15. Pan Y, Xu XD, Guo LL, et al. Association of early versus late initiation of dialysis with mortality: Systematic review and meta-analysis. Nephron Clin Pract 2012; 120: c121-c131.
16. Chang TI, Paik J, Greene T, et al. Updated comorbidity assessments and outcomes in prevalent hemodialysis patients. Hemodial Int 2010; 14: 478-485.
17. Vaiciuniene R, Kuzminskis V, Ziginskiene E, et al. Adherence to treatment and hospitalization risk in hemodialysis patients. J Nephrol 2012; 25: 672-678.
18. McAdams-Demarco MA, Law A, Garonzik-Wang JM, et al. Activity of daily living disability and dialysis mortality: Better prediction using metrics of aging. J Am Geriatr Soc 2012; 60: 1981-1982.
19. Roberts TL, Foley RN, Weinhandl ED, et al. Anaemia and mortality in haemodialysis patients: Interaction of propensity score for predicted anaemia and actual haemoglobin levels. Nephrol Dial Transplant 2006; 21: 1652-1662.
20. Carrero JJ, de Mutsert R, Axelsson J, et al. Sex differences in the impact of diabetes on mortality in chronic dialysis patients. Nephrol Dial Transplant 2011; 26: 270-276.
21. Kalantar-Zadeh K, Block G, Humphreys MH, et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kid Int 2003; 63: 793-808.
22. Port FK, Hulbert-Shearon TE, Wolfe RA, et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kid Dis 1999; 33: 507-517.
23. Longenecker JC, Coresh J, Powe NR, et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE Study. J Am Soc Nephrol 2002; 13: 1918-1927.
24. Beto JA, Bansal VK, Gohlke NP, et al. Using the hemodialysis prognostic nutrition index and urea reduction ratio to predict morbidity and mortality: A pilot study of the 1995 Council on Renal Nutrition national research question. J Renal Nutr 1998; 8: 21-24.
25. Desquilbet L, Jacobson LP, Fried LP, et al. A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men. J Gerontol A Biol Sci Med Sci 2011; 66A: 1030-1038.
26. Desquilbet L, Margolick JB, Fried LP, et al. Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr 2009; 50: 299-306.
27. Bjorntorp P,. Neuroendocrine ageing. J Intern Med 1995; 238: 401-404.
28. Bhavan KP, Kampalath VN, Overton ET,. The aging of the HIV epidemic. Curr HIV/AIDS Rep 2008; 5: 150-158.
29. Martin J, Volberding P,. HIV and premature aging: A field still in its infancy. Ann Intern Med 2010; 153: 477-479.
30. Effros RB, Fletcher CV, Gebo K, et al. Aging and infectious diseases: Workshop on HIV infection and aging: What is known and future research directions. Clin Infect Dis 2008; 47: 542-553.
31. Deeks SG, Phillips AN,. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ 2009; 338: a3172.
32. Bandeen-Roche K, Xue QL, Ferrucci L, et al. Phenotype of frailty: Characterization in the Women's Health and Aging studies. J Gerontol A Biol Sci Med Sci 2006; 61A: 262-266.
33. Barzilay JI, Blaum C, Moore T, et al. Insulin resistance and inflammation as precursors of frailty: The Cardiovascular Health Study. Arch Intern Med 2007; 167: 635-641.
34. Cappola AR, Xue QL, Fried LP,. Multiple hormonal deficiencies in anabolic hormones are found in frail older women: The Women's Health and Aging studies. J Gerontol A Biol Sci Med Sci 2009; 64A: 243-248.
35. Leng SX, Hung W, Cappola AR, et al. White blood cell counts, insulin-like growth factor-1 levels, and frailty in community-dwelling older women. J Gerontol A Biol Sci Med Sci 2009; 64A: 499-502.
36. Leng SX, Xue QL, Tian J, et al. Inflammation and frailty in older women. J Am Geriatr Soc 2007; 55: 864-871.
37. Newman AB, Gottdiener JS, McBurnie MA, et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 2001; 56A: M158-M166.
38. Walston J, McBurnie MA, Newman A, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: Results from the Cardiovascular Health Study. Arch Intern Med 2002; 162: 2333-2341.
39. Xue QL, Bandeen-Roche K, Varadhan R, et al. Initial manifestations of frailty criteria and the development of frailty phenotype in the Women's Health and Aging Study II. J Gerontol A Biol Sci Med Sci 2008; 63A: 984-990.
40. Chang SS, Weiss CO, Xue QL, et al. Association between inflammatory-related disease burden and frailty: Results from the Women's Health and Aging Studies (WHAS) I and II. Arch Gerontol Geriatr 2012; 54: 9-15.
41. Chang SS, Weiss CO, Xue QL, et al. Patterns of comorbid inflammatory diseases in frail older women: The Women's Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci 2010; 65A: 407-413.
42. Katz S, Akpom CA,. A measure of primary sociobiological functions. Int J Health Serv 1976; 6: 493-508.
43. Bao Y, Dalrymple L, Chertow GM, et al. Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch Intern Med 2012; 172: 1071-1077.
44. Johansen KL, Chertow GM, Jin C, et al. Significance of frailty among dialysis patients. J Am Soc Nephrol 2007; 18: 2960-2967.